Objective To investigate the clinical effect of Shenkang Injection combined with cyclophosphamide and hormone in treating refractory nephrotic syndrome. Methods Totally 80 patients with refractory nephrotic syndrome in our hospital from January 2012 to September 2016 were divided into two groups, 40 cases in each group. The control group was treated with cyclophosphamide and hor-mone, on the basis, the observation group was given Shenkang Injection. The clinical effect and biochemical indexes in the two groups were compared. Results The total remission rate of the observation group was 95. 00%, which was significantly higher than 80. 00% of the control group ( P < 0. 05 ) . After treatment, the biochemical indexes of the two groups were statistically different ( P < 0. 05 ) . Conclusion Shenkang Injection combined with cyclophosphamide and hormone in the treatment of refractory nephrotic syndrome has good effect, and it is worthy of clinical promotion.%目的 探讨肾康注射液联合环磷酰胺、激素治疗难治性肾病综合征的临床效果.方法 选择2012年1月至2016年9月医院收治的难治性肾病综合征患者80例,随机分为两组,各40例.对照组给予环磷酰胺、激素治疗,观察组在此基础上加用肾康注射液治疗.比较两组患者的临床疗效及生化指标.结果 观察组总缓解率为95.00%高于对照组的80.00%(P<0.05);两组治疗后生化指标的比较具有统计学差异(P<0.05).结论 在环磷酰胺、激素治疗的基础上联合肾康注射液治疗难治性肾病综合征,疗效确切,值得推广.
展开▼
